Pinealon vs Epithalon
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: EDR, Glu-Asp-Arg
Pinealon is a synthetic tripeptide, Glu-Asp-Arg (the EDR peptide), from the Russian peptide-bioregulator family designed to mimic short signaling peptides found in brain tissue. It is studied as a neuroprotective and antioxidant compound, with researchers proposing it protects neurons from oxidative stress and supports cognition. Be clear-eyed about the evidence: it is essentially all cell-culture and animal work from a small set of related labs, with no human clinical trials and no regulatory approval.
Also: Epitalon, Epithalone
Epithalon (also spelled Epitalon) is a synthetic four-amino-acid peptide, Ala-Glu-Asp-Gly (AEDG), modeled on a natural pineal gland extract. It came out of decades of Russian gerontology research led by Vladimir Khavinson and is marketed as an anti-aging compound that supposedly switches telomerase back on. It has no approval from the FDA, EMA, or other Western regulators, and the human evidence is thin.
Key Comparison Insights
- Both peptides belong to the Bioregulators category, suggesting similar primary applications.
- Epithalon has stronger research evidence (Human Trials) compared to Pinealon (Animal Studies).
Detailed Comparison
| Attribute | Pinealon | Epithalon |
|---|---|---|
| Category | Bioregulators | Bioregulators |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Pinealon (EDR) is one of the short peptides identified in pineal and brain peptide preparations, and like other Khavinson bioregulators it is proposed to work as an epigenetic regulator that enters cells and influences gene expression and protein synthesis. In neuronal cell models it reduces the buildup of reactive oxygen species under oxidative stress, which is the basis for calling it an antioxidant and stress-protector. Reported downstream effects include less necrotic and apoptotic cell death and altered timing of ERK 1/2 signaling and the cell cycle. These are plausible, repeatedly reported in vitro findings, but the idea that such tiny peptides selectively reprogram gene expression in living human brains should be read as a hypothesis that has not been confirmed in people. | The headline claim is telomerase activation. Telomerase is the enzyme that rebuilds telomeres, the protective caps on chromosome ends that shorten as cells divide and age. In cell cultures, Epithalon appears to switch on telomerase in cells that normally lack it, allowing telomeres to lengthen. It is also proposed to influence melatonin production, antioxidant defenses, and gene expression in the pineal-hypothalamic axis. These are real findings in dishes and animals, but the leap from a telomerase signal in a petri dish to actually slowing human aging is a hypothesis, not a proven mechanism. |
| Common Dosing | 10-20 mg daily Once daily, typically evening | 5-10 mg daily for 10-20 days Once daily in cycles |
| Administration | Oral or sublingual | Subcutaneous or intramuscular injection |
| Typical Duration | 10-30 day courses | 10-20 day cycles |
| Best Time to Take | Evening or before bed | Before bed |
Possible Side Effects May vary by individual |
|
|
| Research Summary | The research on pinealon is preclinical and concentrated in Russian peptide-bioregulator literature. In cultured cells, including cerebellar granule neurons, neutrophils and PC12 cells, pinealon dose-dependently limited oxidative-stress-induced ROS accumulation and reduced cell death, and it has been reported to increase cell viability and activate proliferative processes. Related work on the EDR peptide describes neuroprotective gene-expression effects in in vitro and in vivo Alzheimer's-type models, and pinealon is noted to share activity with the brain-peptide drug Cortexin. There are no published randomized human trials, no human safety or pharmacokinetic data, and most of the supporting work originates from a narrow cluster of affiliated groups rather than broad independent replication. The honest bottom line is that pinealon has consistent antioxidant and cell-protective signals in laboratory models and an essentially empty human evidence file. | The cell-level evidence is the strongest part of the story. Khavinson and colleagues (Bulletin of Experimental Biology and Medicine, 2003) showed Epithalon induced telomerase activity and elongated telomeres in cultured human fibroblasts, and a 2025 review in the International Journal of Molecular Sciences summarized its geroprotective and neuroendocrine effects. Animal studies from the same Russian groups reported longer lifespan and reduced tumor incidence in mice and rats. The problem is the human side: replication outside those groups is limited to small, often open-label studies and case reports, with no large, independent, placebo-controlled trials proving it extends human lifespan or reliably lengthens telomeres in people. Its safety record in the published literature looks clean at research doses, but clean and unapproved are not the same as proven. So the honest read is promising preclinical data, real research lineage, and unproven human benefit. |
Frequently Asked Questions: Pinealon vs Epithalon
What is the difference between Pinealon and Epithalon?
Pinealon is a bioregulators peptide that pinealon is a synthetic tripeptide, glu-asp-arg (the edr peptide), from the russian peptide-bioregulator family designed to mimic short signaling peptides found in brain tissue. it is studied as a neuroprotective and antioxidant compound, with researchers proposing it protects neurons from oxidative stress and supports cognition. be clear-eyed about the evidence: it is essentially all cell-culture and animal work from a small set of related labs, with no human clinical trials and no regulatory approval. Epithalon is a bioregulators peptide that epithalon (also spelled epitalon) is a synthetic four-amino-acid peptide, ala-glu-asp-gly (aedg), modeled on a natural pineal gland extract. it came out of decades of russian gerontology research led by vladimir khavinson and is marketed as an anti-aging compound that supposedly switches telomerase back on. it has no approval from the fda, ema, or other western regulators, and the human evidence is thin. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Pinealon or Epithalon?
Neither is universally "better" - the choice depends on your specific goals. Pinealon is typically used for bioregulators purposes, while Epithalon is used for bioregulators. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Pinealon and Epithalon be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Pinealon and Epithalon together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.